<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS190915</article-id><article-id pub-id-type="doi">10.1101/2023.11.09.566419</article-id><article-id pub-id-type="archive">PPR757464</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Dynamics of <italic>Trypanosoma cruzi</italic> infection in hamsters and novel association with progressive motor dysfunction</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Langston</surname><given-names>Harry</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Francisco</surname><given-names>Amanda Fortes</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Doidge</surname><given-names>Ciaran</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">3</xref></contrib><contrib contrib-type="author"><name><surname>Roberts</surname><given-names>Chrissy H.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Archie A.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jayawardhana</surname><given-names>Shiromani</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>Martin C.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kelly</surname><given-names>John M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Michael D.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, U.K.</aff><aff id="A2"><label>2</label>Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, U.K.</aff><author-notes><fn id="FN1" fn-type="present-address"><label>3</label><p id="P1">Current Address: Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, U.K.</p></fn><fn id="FN2" fn-type="present-address"><label>4</label><p id="P2">Current Address: Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, CV4 7AJ, U.K.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>09</day><month>11</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P3">Chagas disease is a zoonosis caused by the protozoan parasite <italic>Trypanosoma cruzi</italic>. Clinical outcomes range from long-term asymptomatic carriage to cardiac, digestive, neurological and composite presentations that can be fatal in both acute and chronic stages of the disease. Studies of <italic>T. cruzi</italic> in animal models, principally mice, have informed our understanding of the biological basis of this variability and its relationship to infection and host response dynamics. Hamsters have higher translational value for many human infectious diseases, but they have not been well developed as models of Chagas disease. We transposed a real-time bioluminescence imaging system for <italic>T. cruzi</italic> infection from mice into female Syrian hamsters (<italic>Mesocricetus auratus</italic>). This enabled us to study chronic tissue pathology in the context of spatiotemporal infection dynamics. Acute infections were widely disseminated, whereas chronic infections were almost entirely restricted to the skin and subcutaneous adipose tissue. Neither cardiac nor digestive tract disease were reproducible features of the model. Skeletal muscle had only sporadic parasitism in the chronic phase, but nevertheless displayed significant inflammation and fibrosis, features also seen in mouse models. Whereas mice had normal locomotion, all chronically infected hamsters developed hindlimb muscle hypertonia and a gait dysfunction resembling spastic diplegia. With further development, this model may therefore prove valuable in studies of peripheral nervous system involvement in Chagas disease.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P4">Chagas disease (American trypanosomiasis) is caused by infection with <italic>Trypanosoma cruzi</italic>, a protozoan parasite. Approximately 6 million people are infected and the disease causes ~10,000 deaths annually as well as a large morbidity burden in affected populations (<xref ref-type="bibr" rid="R1">1</xref>). Clinical outcomes are highly heterogeneous, encompassing muscle and nervous tissue pathologies affecting the heart and gastro-intestinal tract, as well as long-term asymptomatic carriage (<xref ref-type="bibr" rid="R2">2</xref>) Pathogenesis is thought to be primarily a result of collateral damage to infected tissues from the host’s cellular immune response, which leads to fibrosis, microvascular abnormalities, denervation and consequent organ dysfunction (<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref>).</p><p id="P5">Animal infection models are critical to research on the biological basis of Chagas disease. <italic>T. cruzi</italic> is a very cosmopolitan parasite in its natural host range (<xref ref-type="bibr" rid="R6">6</xref>) and a variety of species have been used in experimental settings, including rats, rabbits, dogs, guinea pigs, opossums and non-human primates, often reproducing important features of the human disease spectrum (<xref ref-type="bibr" rid="R7">7</xref>). Mice, however, are by far the most widely used species; in most cases they develop inflammatory cardiomyopathy and a few models are suitable for studying aspects of digestive disease. The compatibility of murine models with technologies such as bioluminescence imaging (BLI), which enable real-time monitoring of infections, is a major advantage and has led to significant advances in understanding how spatio-temporal infection dynamics relate to pathology development (<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref>). Mice have been less well developed as models of advanced digestive megasyndromes, peripheral neuropathy or CNS infection, an important cause of acute mortality in human patients (<xref ref-type="bibr" rid="R11">11</xref>). Furthermore, the use of a few inbred mouse strains limits our ability to study the impact of host genetic diversity on disease pathogenesis and clinical outcome heterogeneity.</p><p id="P6">The aim of this study was to develop an <italic>in vivo/ex vivo</italic> BLI system for <italic>T. cruzi</italic> infection in the Syrian hamster, <italic>Mesocricetus auratus</italic>. Hamsters can show closer alignment with human diseases than mice for a variety of infectious agents, for example <italic>Clostridium difficile</italic>, SARS-CoV-2, West Nile Virus, adenoviruses, <italic>Leishmania donovani</italic> and <italic>Schistosoma haematobium</italic> (<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R16">16</xref>). Hamsters have also been described as useful models of Chagas cardiac disease (<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R23">23</xref>) and in some cases are reported to develop a dilated large intestine indicative of megacolon (<xref ref-type="bibr" rid="R18">18</xref>). They are also one of the few species readily available, besides mice, whose physical size is compatible with standard <italic>in vivo</italic> imaging chambers. We therefore reasoned that a hamster <italic>T. cruzi</italic> BLI system could add value to the landscape of experimental Chagas disease <italic>in vivo</italic> models.</p></sec><sec id="S2" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S3"><title>Parasites, animals and infections</title><p id="P7"><italic>T. cruzi</italic> CL Brener (genetic lineage TcVI) constitutively expressing the red-shifted firefly luciferase gene <italic>PpyRE9h</italic> (<xref ref-type="bibr" rid="R24">24</xref>) were used in all experiments. Infectious trypomastigotes were generated as previously described (<xref ref-type="bibr" rid="R24">24</xref>). Animals used were female CB17 SCID mice aged 8 – 10 weeks (bred in house), female BALB/c, C57BL6 and C3H/HeN mice aged 6 – 8 weeks (Charles River) and female Syrian hamsters aged 6 – 8 weeks old (Janvier Labs). Animals were acclimatised to the vivarium for 1 – 2 weeks prior to use in experiments. SCID mice were infected with 10<sup>4</sup> trypomastigotes and all other mice were infected with 10<sup>3</sup> trypomastigotes. Hamsters were infected with 5 x 10<sup>3</sup> or 10<sup>5</sup> trypomastigotes. Inocula were given as intra-peritoneal (i.p.) injections of 0.2 mL in sterile 1X Dulbecco’s Phosphate Buffered Saline (DPBS).</p><p id="P8">Animal work was approved by the LSHTM Animal Welfare and Ethical Review Board and carried out under UK Home Office project licence (PPL 70/8207) in accordance with the UK Animals (Scientific Procedures) Act. Animals were maintained under specific pathogen-free conditions in individually ventilated cages, with 2 – 3 hamsters and 5 – 6 mice per cage, with a 12 hour light/dark cycle and <italic>ad libitum</italic> food and water.</p></sec><sec id="S4"><title>Bioluminescence imaging</title><p id="P9">Hamsters were injected with 150 mg/kg d-luciferin i.p., then anaesthetized using 2.5% (v/v) gaseous isoflurane in oxygen. To measure bioluminescence, hamsters were placed in a Lumina II In Vivo Imaging System (IVIS) (PerkinElmer) and images were acquired 10 – 20 minutes after d-luciferin administration using LivingImage v4.7. A custom 3D printed nosecone was used for continuous isoflurane delivery during imaging sessions (<xref ref-type="supplementary-material" rid="SD1">Supplementary Data File 1</xref>). Exposure times varied between 30 seconds and 5 minutes, depending on bioluminescence signal intensity. After imaging, animals were revived and returned to cages. For <italic>ex vivo</italic> imaging, hamsters were injected with 150 mg/kg d-luciferin i.p., then sacrificed by ex-sanguination under terminal anaesthesia (400-600 mg/kg Pentobarbital Sodium) 7 minutes later. Trans-cardiac perfusion was performed with 20 mL 0.3 mg/mL d-luciferin in PBS. Organs and tissues were transferred to culture dishes, soaked in 0.3 mg/mL d-luciferin in PBS, and then imaged using the IVIS Lumina II. One hamster from the low inoculum group was excluded from further analysis because a bioluminescence signal was never detected, indicating that infection did not become established.</p><p id="P10">To estimate total parasite loads in live hamsters, regions of interest (ROIs) were drawn using Living Image v4.7 to quantify bioluminescence expressed as total flux (photons/second [p/s]). The detection threshold for <italic>in vivo</italic> imaging was determined using uninfected control hamsters. The line measurement tool in Living Image was used to quantify the degree of limb adduction by determining the distance between the two forepaws and between the two hindpaws in each image.</p><p id="P11"><italic>Ex vivo</italic> images of tissues and organs were scored for the presence of <italic>T. cruzi</italic> using a detection threshold for infection foci of at least 10 contiguous bioluminescent pixels of radiance ≥3x10<sup>3</sup> p/s/cm<sup>2</sup>/sr (<xref ref-type="bibr" rid="R8">8</xref>). Tissue/organ-specific infection intensities were calculated as the fold change in bioluminescence radiance (p/s/cm<sup>2</sup>/sr), which normalises for differences in tissue sample volumes, compared with the mean radiance for the same tissue/organ type measured for uninfected control hamsters (n = 7).</p><sec id="S5"><title>Histopathology</title><p id="P12">Tissue samples were fixed in Glyo-Fixx (Epredia) for 24 – 72 hours, then dehydrated in an ethanol series, cleared in xylene (Sigma), and embedded in paraffin for histomorphometric analysis (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>). Five-micron tissue sections were stained with Haematoxylin and Eosin (H&amp;E), picrosirius red or Masson’s trichrome and analysed using a DFC295 camera attached to a DM3000 light-emitting diode microscope (Leica) as described (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>). Images were digitised using Leica Application Suite v4.5.0. For the inflammatory index, the total number of nuclei were counted in 10 - 15 randomly selected microscope fields of view (FOV, area at 400X magnification = 2.66 x 10<sup>5</sup> μm<sup>2</sup>) per animal in H&amp;E-stained sections. An inflammation index was calculated as the average cellularity (mean number of nuclei per FOV) for each animal. A significant increase in cellularity compared to uninfected controls was considered indicative of inflammation. For the fibrosis index, the proportion of total FOV area positive for collagen in picrosirius red- or Masson’s trichrome stained sections (red or blue pixels respectively) was quantified, also in Leica Application Suite v4.5.0. A significant increase in collagen content compared to uninfected controls was considered indicative of fibrosis.</p></sec></sec><sec id="S6"><title>Statistics</title><p id="P13">Individual animals were used as the unit of analysis. Groups were compared using Student’s <italic>t</italic>-test or one-way ANOVA, with Tukey’s post-hoc correction in GraphPad Prism v.8.</p></sec></sec><sec id="S7" sec-type="results"><title>Results</title><sec id="S8"><title>In vivo bioluminescence imaging permits long-term tracking of T. cruzi infection in hamsters</title><p id="P14">We infected hamsters with either a low (5,000) or high (100,000) inoculum of <italic>T. cruzi</italic> TcVI-CLBR trypomastigotes expressing the red-shifted luciferase reporter <italic>PPyRE9h</italic> (<xref ref-type="bibr" rid="R24">24</xref>). The resulting infections were monitored regularly by <italic>in vivo</italic> bioluminescence imaging (<xref ref-type="fig" rid="F1">Figures 1A, 1B</xref>). For both inocula, parasite burdens proceeded through a typical acute phase wave that transitioned into a stable, long-term chronic infection. In the high inoculum group, the acute phase was 3-fold more intense and its peak occurred at 2 weeks post-infection (p.i.) rather than 4 weeks p.i. for the low inoculum group (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Spatially, <italic>in vivo</italic> imaging indicated that the acute phase infection was highly concentrated near to the injection site in the abdomen, but from 8 weeks p.i. onwards, the bioluminescence signal became widely distributed, multi-focal and dynamic between analysis time-points (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The size of the inoculum did not affect the level at which chronic parasite burdens stabilised, nor the spatio-temporal distribution of the infection. For further analyses, we focussed on the high inoculum approach because acute infections in the low inoculum group tended to be more variable.</p><p id="P15">Monitoring of animals identified gait abnormalities gradually developing during the chronic phase of infection, with pronounced hindlimb rigidity. Muscle mass was observed to be within normal limits at post-mortem. With respect to potential features of human Chagas disease, we observed significant splenomegaly, but no sign of cardiomegaly, digestive megasyndromes or constipation at the experimental end-point of 152-182 days p.i. (<xref ref-type="fig" rid="F1">Figure 1C</xref>).</p></sec><sec id="S9"><title>Skin is the primary reservoir of chronic parasite persistence in hamsters</title><p id="P16"><italic>T. cruzi</italic> displays a very broad cell and tissue tropism, but <italic>in vivo</italic> imaging does not permit unambiguous localisation of signals to organs. Therefore, to better understand infection dynamics in this model we conducted <italic>ex vivo</italic> bioluminescence imaging post-mortem, at the acute-chronic transition (34-38 days p.i.) and in the established chronic phase (152-182 days p.i.) (<xref ref-type="fig" rid="F2">Figure 2A</xref>). At 34-38 days p.i., infection was almost universally detected across all the tissues and organs that were sampled (<xref ref-type="fig" rid="F2">Figure 2A, 2B, 2D, 2F</xref>). In terms of absolute parasite loads (total bioluminescent flux/sec), the skin harboured the greatest proportion of parasites (58.0% ±19.2%) followed by several fat-rich organs each containing 5-10% of the total (GI mesentery, genito-urinary system, subcutaneous adipose, visceral adipose) (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Infection intensity, which takes into account the large variation in organ size, varied over more than three orders of magnitude. Of note, parasite loads measured in this way were relatively high in the skin, adipose, GI mesentery and genito-urinary system, moderately high in striated muscles (heart, skeletal muscle, abdomen/peritoneum) and relatively low in the GI tract, liver and spleen (<xref ref-type="fig" rid="F2">Figure 2F</xref>).</p><p id="P17">In the established chronic phase, infection became undetectable in the majority of sites in the majority of individual animals (<xref ref-type="fig" rid="F2">Figure 2A, 2C, 2E, 2G</xref>). It should be noted that the limit of detection is &lt;20 parasites in the mouse colon (<xref ref-type="bibr" rid="R25">25</xref>), but the larger size of hamster organs likely reduces detection sensitivity. Persistent infection was mainly restricted to the skin and subcutaneous adipose tissue, with sporadic, usually small foci of infection in a few other organs, most often the skeletal muscle, spleen and lungs. In contrast to mouse models (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref>), parasites were only rarely detected in the GI tract during the chronic stage. Considering absolute numbers, the skin harboured a large majority of the total parasites (93.4% ±3.8%) (<xref ref-type="fig" rid="F2">Figure 2D, 2E</xref>) and also had the highest infection intensity (<xref ref-type="fig" rid="F2">Figure 2G</xref>). Skin parasites could be detected in any skin region, and in the chronic phase they were typically present in approximately 20 to 30 discrete foci of infection (<xref ref-type="fig" rid="F2">Figure 2A</xref>).</p></sec><sec id="S10"><title>Occurrence of a hindlimb spastic diplegia-like syndrome in the hamster infection model</title><p id="P18">Cardiomyopathy is the most serious adverse clinical consequence of chronic <italic>T. cruzi</italic> infection in humans. Histopathology analysis of heart tissue samples from hamsters at 5 months p.i. indicated that inflammation and collagen content (a measure of fibrosis) were not significantly increased compared to uninfected control animals at the group mean level (<xref ref-type="fig" rid="F3">Figure 3</xref>). However, some animals did display clear evidence of oedema, focal and diffuse inflammatory foci, and intermuscular fibro-fatty tissue replacement.</p><p id="P19">To better understand the gait abnormality that arose in the hamsters, we assessed its development over time (<xref ref-type="fig" rid="F4">Figure 4A</xref>). This identified excessive bilateral hindlimb adduction, which was clearly progressive over the course of chronic infection and resembled the “scissor gait” seen in a number of human neuromuscular disorders, such as cerebral palsy (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref>). The phenotype was highly significant and developed in 100% of chronically infected hamsters (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Histopathological analysis of hindlimb skeletal muscle identified significant perivascular and muscle parenchymal inflammation, fibrosis and fatty degeneration (<xref ref-type="fig" rid="F5">Figure 5</xref>). To investigate whether the gait abnormality might be linked to the myositis (muscle inflammation) and intense fibrosis, we investigated if these histopathological features developed in a range of murine <italic>T. cruzi</italic> infection models (parasite strains TcI-JR and TcVI-CLBR in BALB/c, C57BL/6 and C3H/HeN mice), none of which develop the diplegia symptoms seen in hamsters. Significant myositis was present in 5 of the 6 parasite-mouse strain combinations, TcI-JR in C3H/HeN mice being the exception, and significant fibrosis was present in all 6 models (<xref ref-type="fig" rid="F6">Figure 6</xref>). Both phenotypes occurred with a range of severities, with the most affected mouse models being broadly comparable to the hamster model: cellularity (myositis) increased 3-fold in TcVI-CLBR:C3H/HeN vs 4-fold for TcVI-CLBR:Hamster, and collagen content (fibrosis) increased ~4.5 fold in TcVI-CLBR:C3H/HeN vs 2-fold for TcVI-CLBR:Hamster. Fatty degeneration and parasite nests were also occasionally observed in murine skeletal muscle tissue. Thus, the diplegic gait in hamsters is highly unlikely to result directly from chronic parasite persistence, skeletal muscle inflammation or fibrosis, because these are all also common features of murine infections. A neuropathic aetiology therefore seems probable.</p></sec></sec><sec id="S11" sec-type="discussion"><title>Discussion</title><p id="P20">Bioluminescence imaging has been widely applied to <italic>T. cruzi</italic> murine infections, but its utility to monitor Chagas disease progression in larger rodents has not been reported. Our aims were to investigate if this technology could provide new insights into parasite distribution patterns during long-term <italic>T. cruzi</italic> infection of hamsters and to establish if there was a link with pathological outcomes. The results demonstrate that <italic>in vivo</italic> imaging, using the highly sensitive system described here, is able to facilitate longitudinal monitoring of chronic <italic>T. cruzi</italic> infections in hamsters. Furthermore, <italic>ex vivo</italic> imaging revealed organ and tissue parasite tropism during both acute and chronic stage infections, and identified the reservoir sites within the hamster that provide a niche for long-term parasite survival.</p><p id="P21">There were both similarities and differences in comparison with typical infection profiles in mice, with one commonality being the pan-tropism of acute stage infections (<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R32">32</xref>). In terms of the heart, hamsters did not have detectable chronic infections localised to this organ and signs of cardiac pathology were only observed in a small subset of animals. Cardiac pathology typically is present in mice, although severity can vary substantially between parasite and mouse strains as, well as between individual animals, even when they are inbred (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R35">35</xref>). The observation of a low rate of cardiomyopathy in hamsters may be significant, given that they are an outbred model, and only a minority of humans infected with <italic>T. cruzi</italic> develop heart disease symptoms (<xref ref-type="bibr" rid="R36">36</xref>). Previous studies in hamsters have reported more consistent cardiomyopathy as well as mortality rates ranging from 12 – 80% (<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R37">37</xref>). However, here we observed 100% survival. This could reflect differences in virulence between strains because TcVI-CLBR also has low mortality, &lt;10%, in mice in our laboratory (<xref ref-type="bibr" rid="R9">9</xref>). In addition, the 5-6 month post-infection period to which our study was limited may have been too short for cardiac pathology to develop more reproducibly.</p><p id="P22">Regarding the digestive tract, localised chronic infections were absent, apart from a few very weak bioluminescence signals in one or two animals. No signs of organ enlargement or constipation, characteristic of digestive Chagas disease, were found. This contrasts with murine infections, where the GI tract is a major and almost universal site of long-term parasite persistence and chronic transit delays linked to the colon are significant in some parasite-mouse strain combinations (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R41">41</xref>). GI tract samples from digestive Chagas disease patients have high frequencies of parasite DNA/antigen positivity (<xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R45">45</xref>). Overall, these data indicate that Syrian hamster infection with TcVI-CLBR is not a suitable model to study the cardiac or the digestive form of Chagas disease.</p><p id="P23">Two findings from the study are particularly noteworthy. Firstly. the predominance of the skin as a chronic reservoir of infection, and secondly, the hindlimb diplegic gait phenotype. In mouse models, we have shown that chronic skin infection is present in 80-90% of mice across multiple combinations of <italic>T. cruzi</italic> and host genetic strains (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R25">25</xref>). Whereas in mice the skin and GI tract have a similar reservoir status, in the hamster our data indicate that the skin and subcutaneous adipose tissue harbour almost the entire parasite burden in the animal. Acute cutaneous manifestations of Chagas disease reported in humans include localised inoculation ‘chagomas’ – swellings associated with initial parasite entry sites (<xref ref-type="bibr" rid="R2">2</xref>) and, very rarely, more disseminated lesions (<xref ref-type="bibr" rid="R46">46</xref>). Skin lesions may also occur in cases of ‘re-activation’ of a chronic infection in which immunosuppression, for example caused by HIV co-infection or post-transplant medications, causes expansion and spread of the parasite burden (<xref ref-type="bibr" rid="R47">47</xref>, <xref ref-type="bibr" rid="R48">48</xref>). Although chronic <italic>T. cruzi</italic> infection in immunocompetent people is not associated with cutaneous pathology, this does not rule out the existence of a clinically silent skin-resident parasite population. This would have an obvious evolutionary advantage for <italic>T. cruzi</italic> in terms of ensuring onward transmission to its blood-feeding insect vector and would be in keeping with the biology of related trypanosomatids, such as <italic>T. brucei</italic> and <italic>Leishmania donovani</italic> (<xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R50">50</xref>). It may also be relevant that the skin is the most common site affected by adverse reactions to the anti-parasitic drugs that are used to treat Chagas disease (<xref ref-type="bibr" rid="R51">51</xref>).</p><p id="P24">Skeletal muscle is a preferred site of infection for numerous human parasites e.g. <italic>Sarcocystis</italic>,. <italic>Toxoplasma, Brugia, Ancylostoma</italic>, and <italic>Trichinella</italic> spp., (<xref ref-type="bibr" rid="R52">52</xref>). Parasitism of this tissue is common in <italic>T. cruzi</italic> infected mice, though the frequency and intensity appears to be rather model-dependent (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R53">53</xref>). We observed hindlimb skeletal muscle-localised parasite bioluminescence in all hamsters at 34-38 days p.i., and in approximately half of them at 152-182 days p.i., although the infection intensity was relatively low. This tissue was characterised by significant chronic parenchymal and perivascular inflammation and fibrosis, which was also present in all six of the mouse models that we analysed. The hindlimb hypertonia and diplegic gait were hamster-specific; no locomotion defects were observed in mice, implying that tissue parasitism, inflammation and fibrosis are insufficient explanations. A motor neuron aetiology is probably the most suitable hypothesis for future work. Others have reported limb paralysis in <italic>T. cruzi</italic> infected mice (<xref ref-type="bibr" rid="R54">54</xref>, <xref ref-type="bibr" rid="R55">55</xref>), but that is clearly a different phenomenon. While neither type of locomotive dysfunction have been linked to <italic>T. cruzi</italic> infection in humans, there is evidence of peripheral nervous system involvement in some Chagas disease cohorts at frequencies of 10% (<xref ref-type="bibr" rid="R56">56</xref>) to 27% (<xref ref-type="bibr" rid="R57">57</xref>). Skeletal muscle denervation, neuro-muscular junction, microvascular, mitochondrial and metabolic abnormalities have all been described (<xref ref-type="bibr" rid="R58">58</xref>–<xref ref-type="bibr" rid="R62">62</xref>). These are evidently under-studied aspects of Chagas disease and the potential translational value of the hamster model developed in this study should be explored further. It may also prove relevant to wider research on spastic diplegia.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Data</label><media xlink:href="EMS190915-supplement-Supplementary_Data.zip" mimetype="application" mime-subtype="zip" id="d85aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S12"><title>Acknowledgements</title><p>The authors thank the LSHTM Biological Services Facility staff for technical support. The research was supported by UK Medical Research Council (MRC) grants MR/T015969/1 to J.M.K. and MR/R021430/1 to M.D.L.</p></ack><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Ochoa</surname><given-names>SA</given-names></name><name><surname>Rojas</surname><given-names>LZ</given-names></name><name><surname>Echeverría</surname><given-names>LE</given-names></name><name><surname>Muka</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name></person-group><article-title>Global, regional, and national trends of Chagas disease from 1990 to 2019: comprehensive analysis of the global burden of disease study</article-title><source>Global heart</source><year>2022</year><volume>17</volume><issue>1</issue><pub-id pub-id-type="pmcid">PMC9414802</pub-id><pub-id pub-id-type="pmid">36051318</pub-id><pub-id pub-id-type="doi">10.5334/gh.1150</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Molina</surname><given-names>JA</given-names></name><name><surname>Molina</surname><given-names>I</given-names></name></person-group><article-title>Chagas disease</article-title><source>Lancet (London, England)</source><year>2018</year><volume>391</volume><issue>10115</issue><fpage>82</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">28673423</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin-Neto</surname><given-names>JA</given-names></name><name><surname>Cunha-Neto</surname><given-names>E</given-names></name><name><surname>Maciel</surname><given-names>BC</given-names></name><name><surname>Simoes</surname><given-names>MV</given-names></name></person-group><article-title>Pathogenesis of chronic Chagas heart disease</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>9</issue><fpage>1109</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">17339569</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonney</surname><given-names>KM</given-names></name><name><surname>Luthringer</surname><given-names>DJ</given-names></name><name><surname>Kim</surname><given-names>SA</given-names></name><name><surname>Garg</surname><given-names>NJ</given-names></name><name><surname>Engman</surname><given-names>DM</given-names></name></person-group><article-title>Pathology and Pathogenesis of Chagas Heart Disease</article-title><source>Annual Review of Pathology: Mechanisms of Disease</source><year>2019</year><volume>14</volume><issue>1</issue><fpage>421</fpage><lpage>47</lpage><pub-id pub-id-type="pmcid">PMC7373119</pub-id><pub-id pub-id-type="pmid">30355152</pub-id><pub-id pub-id-type="doi">10.1146/annurev-pathol-020117-043711</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>FS</given-names></name><name><surname>Dutra</surname><given-names>WO</given-names></name><name><surname>Esper</surname><given-names>L</given-names></name><name><surname>Gollob</surname><given-names>KJ</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Factor</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Current understanding of immunity to <italic>Trypanosoma cruzi</italic> infection and pathogenesis of Chagas disease</article-title><source>Seminars in Immunopathology</source><year>2012</year><volume>34</volume><issue>6</issue><fpage>753</fpage><lpage>70</lpage><pub-id pub-id-type="pmcid">PMC3498515</pub-id><pub-id pub-id-type="pmid">23076807</pub-id><pub-id pub-id-type="doi">10.1007/s00281-012-0351-7</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>AM</given-names></name><name><surname>Xavier</surname><given-names>S</given-names></name><name><surname>Roque</surname><given-names>ALR</given-names></name></person-group><article-title>Trypanosoma cruzi transmission in the wild and its most important reservoir hosts in Brazil</article-title><source>Parasit Vectors</source><year>2018</year><volume>11</volume><issue>1</issue><fpage>502</fpage><pub-id pub-id-type="pmcid">PMC6127949</pub-id><pub-id pub-id-type="pmid">30189896</pub-id><pub-id pub-id-type="doi">10.1186/s13071-018-3067-2</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatelain</surname><given-names>E</given-names></name><name><surname>Konar</surname><given-names>N</given-names></name></person-group><article-title>Translational challenges of animal models in Chagas disease drug development: a review</article-title><source>Drug design, development and therapy</source><year>2015</year><volume>9</volume><fpage>4807</fpage><pub-id pub-id-type="pmcid">PMC4548737</pub-id><pub-id pub-id-type="pmid">26316715</pub-id><pub-id pub-id-type="doi">10.2147/DDDT.S90208</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>MD</given-names></name><name><surname>Francisco</surname><given-names>AF</given-names></name><name><surname>Jayawardhana</surname><given-names>S</given-names></name><name><surname>Langston</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>MC</given-names></name><name><surname>Kelly</surname><given-names>JM</given-names></name></person-group><article-title>Imaging the development of chronic Chagas disease after oral transmission</article-title><source>Scientific Reports</source><year>2018</year><volume>8</volume><issue>1</issue><elocation-id>11292</elocation-id><pub-id pub-id-type="pmcid">PMC6062536</pub-id><pub-id pub-id-type="pmid">30050153</pub-id><pub-id pub-id-type="doi">10.1038/s41598-018-29564-7</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>MD</given-names></name><name><surname>Francisco</surname><given-names>AF</given-names></name><name><surname>Taylor</surname><given-names>MC</given-names></name><name><surname>Jayawardhana</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>JM</given-names></name></person-group><article-title>Host and parasite genetics shape a link between <italic>Trypanosoma cruzi</italic> infection dynamics and chronic cardiomyopathy</article-title><source>Cell Microbiol</source><year>2016</year><volume>18</volume><issue>10</issue><fpage>1429</fpage><lpage>43</lpage><pub-id pub-id-type="pmcid">PMC5031194</pub-id><pub-id pub-id-type="pmid">26918803</pub-id><pub-id pub-id-type="doi">10.1111/cmi.12584</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AA</given-names></name><name><surname>Langston</surname><given-names>HC</given-names></name><name><surname>Costa</surname><given-names>FC</given-names></name><name><surname>Olmo</surname><given-names>F</given-names></name><name><surname>Taylor</surname><given-names>MC</given-names></name><name><surname>McCann</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Local association of <italic>Trypanosoma cruzi</italic> chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale</article-title><source>PLoS Pathog</source><year>2021</year><volume>17</volume><issue>8</issue><elocation-id>e1009864</elocation-id><pub-id pub-id-type="pmcid">PMC8412264</pub-id><pub-id pub-id-type="pmid">34424944</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009864</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkowitz</surname><given-names>AL</given-names></name><name><surname>Raibagkar</surname><given-names>P</given-names></name><name><surname>Pritt</surname><given-names>BS</given-names></name><name><surname>Mateen</surname><given-names>FJ</given-names></name></person-group><article-title>Neurologic manifestations of the neglected tropical diseases</article-title><source>J Neurol Sci</source><year>2015</year><volume>349</volume><issue>1-2</issue><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">25623803</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>A</given-names></name><name><surname>Domínguez-Bernal</surname><given-names>G</given-names></name><name><surname>Orden</surname><given-names>JA</given-names></name><name><surname>De La Fuente</surname><given-names>R</given-names></name><name><surname>Madrid-Elena</surname><given-names>N</given-names></name><name><surname>Carrión</surname><given-names>J</given-names></name></person-group><article-title>Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model</article-title><source>Veterinary Research</source><year>2011</year><volume>42</volume><issue>1</issue><fpage>39</fpage><pub-id pub-id-type="pmcid">PMC3052183</pub-id><pub-id pub-id-type="pmid">21345200</pub-id><pub-id pub-id-type="doi">10.1186/1297-9716-42-39</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Ying</surname><given-names>B</given-names></name><name><surname>Spencer</surname><given-names>JF</given-names></name><name><surname>Tollefson</surname><given-names>AE</given-names></name><name><surname>Sagartz</surname><given-names>JE</given-names></name><etal/></person-group><article-title>STAT2 knockout Syrian hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control</article-title><source>PLoS pathogens</source><year>2015</year><volume>11</volume><issue>8</issue><elocation-id>e1005084</elocation-id><pub-id pub-id-type="pmcid">PMC4546297</pub-id><pub-id pub-id-type="pmid">26291525</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005084</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutton</surname><given-names>ML</given-names></name><name><surname>Mackin</surname><given-names>KE</given-names></name><name><surname>Chakravorty</surname><given-names>A</given-names></name><name><surname>Lyras</surname><given-names>D</given-names></name></person-group><article-title>Small animal models for the study of Clostridium difficile disease pathogenesis</article-title><source>FEMS Microbiology Letters</source><year>2014</year><volume>352</volume><issue>2</issue><fpage>140</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24372713</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C-Y</given-names></name><name><surname>Lowen</surname><given-names>AC</given-names></name></person-group><article-title>Animal models for SARS-CoV-2</article-title><source>Current opinion in virology</source><year>2021</year><volume>48</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="pmcid">PMC8023231</pub-id><pub-id pub-id-type="pmid">33906125</pub-id><pub-id pub-id-type="doi">10.1016/j.coviro.2021.03.009</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>J</given-names></name><name><surname>Chard</surname><given-names>LS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Syrian Hamster as an Animal Model for the Study on Infectious Diseases</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>2329</fpage><pub-id pub-id-type="pmcid">PMC6781508</pub-id><pub-id pub-id-type="pmid">31632404</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02329</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrine-Santos</surname><given-names>M</given-names></name><name><surname>Lages Silva</surname><given-names>E</given-names></name><name><surname>Chapadeiro</surname><given-names>E</given-names></name><name><surname>Ramírez</surname><given-names>LE</given-names></name></person-group><article-title><italic>Trypanosoma cruzi</italic>: characterization of reinfection and search for tissue tropism in hamsters (<italic>Mesocricetus auratus</italic>)</article-title><source>Experimental parasitology</source><year>2001</year><volume>99</volume><issue>3</issue><fpage>160</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11846526</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname><given-names>LE</given-names></name><name><surname>Lages-Silva</surname><given-names>E</given-names></name><name><surname>Soares</surname><given-names>JM</given-names><suffix>Júnior</suffix></name><name><surname>Chapadeiro</surname><given-names>E</given-names></name></person-group><article-title>The hamster (<italic>Mesocricetus auratus</italic>) as experimental model in Chagas’ disease: parasitological and histopathological studies in acute and chronic phases of <italic>Trypanosoma cruzi</italic> infection</article-title><source>Rev Soc Bras Med Trop</source><year>1994</year><volume>27</volume><issue>3</issue><fpage>163</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7972946</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramires</surname><given-names>FJ</given-names></name><name><surname>Salemi</surname><given-names>VM</given-names></name><name><surname>Ianni</surname><given-names>BM</given-names></name><name><surname>Fernandes</surname><given-names>F</given-names></name><name><surname>Martins</surname><given-names>DG</given-names></name><name><surname>Billate</surname><given-names>A</given-names></name><etal/></person-group><article-title>Aldosterone antagonism in an inflammatory state: evidence for myocardial protection</article-title><source>J Renin Angiotensin Aldosterone Syst</source><year>2006</year><volume>7</volume><issue>3</issue><fpage>162</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17094053</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilate</surname><given-names>AM</given-names></name><name><surname>Teixeira</surname><given-names>PC</given-names></name><name><surname>Ribeiro</surname><given-names>SP</given-names></name><name><surname>Brito</surname><given-names>T</given-names></name><name><surname>Silva</surname><given-names>AM</given-names></name><name><surname>Russo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Distinct outcomes of <italic>Trypanosoma cruzi</italic> infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression, and protein expression profile</article-title><source>J Infect Dis</source><year>2008</year><volume>198</volume><issue>4</issue><fpage>614</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">18598198</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilate</surname><given-names>AM</given-names></name><name><surname>Salemi</surname><given-names>VM</given-names></name><name><surname>Ramires</surname><given-names>FJ</given-names></name><name><surname>de Brito</surname><given-names>T</given-names></name><name><surname>Silva</surname><given-names>AM</given-names></name><name><surname>Umezawa</surname><given-names>ES</given-names></name><etal/></person-group><article-title>The Syrian hamster as a model for the dilated cardiomyopathy of Chagas’ disease: a quantitative echocardiographical and histopathological analysis</article-title><source>Microbes and Infection</source><year>2003</year><volume>5</volume><issue>12</issue><fpage>1116</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">14554253</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapadeiro</surname><given-names>E</given-names></name><name><surname>Silva</surname><given-names>EL</given-names></name><name><surname>Silva</surname><given-names>AC</given-names></name><name><surname>Fernandes</surname><given-names>P</given-names></name><name><surname>Ramirez</surname><given-names>LE</given-names></name></person-group><article-title>Cardiac neuronal depopulation in hamsters (<italic>Mesocricetus auratus</italic>) chronically infected with <italic>Trypanosoma cruzi</italic></article-title><source>Rev Soc Bras Med Trop</source><year>1999</year><volume>32</volume><issue>1</issue><fpage>35</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9927823</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimentel</surname><given-names>WS</given-names></name><name><surname>Ramires</surname><given-names>FJ</given-names></name><name><surname>Lanni</surname><given-names>BM</given-names></name><name><surname>Salemi</surname><given-names>VM</given-names></name><name><surname>Bilate</surname><given-names>AM</given-names></name><name><surname>Cunha-Neto</surname><given-names>E</given-names></name><etal/></person-group><article-title>The effect of beta-blockade on myocardial remodelling in Chagas’ cardiomyopathy</article-title><source>Clinics (Sao Paulo)</source><year>2012</year><volume>67</volume><issue>9</issue><fpage>1063</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC3438248</pub-id><pub-id pub-id-type="pmid">23018305</pub-id><pub-id pub-id-type="doi">10.6061/clinics/2012(09)14</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>MD</given-names></name><name><surname>Francisco</surname><given-names>AF</given-names></name><name><surname>Taylor</surname><given-names>MC</given-names></name><name><surname>Burrell-Saward</surname><given-names>H</given-names></name><name><surname>McLatchie</surname><given-names>AP</given-names></name><name><surname>Miles</surname><given-names>MA</given-names></name><name><surname>Kelly</surname><given-names>JM</given-names></name></person-group><article-title>Bioluminescence imaging of chronic <italic>Trypanosoma cruzi</italic> infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection</article-title><source>Cell Microbiol</source><year>2014</year><volume>16</volume><issue>9</issue><fpage>1285</fpage><lpage>300</lpage><pub-id pub-id-type="pmcid">PMC4190689</pub-id><pub-id pub-id-type="pmid">24712539</pub-id><pub-id pub-id-type="doi">10.1111/cmi.12297</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>AI</given-names></name><name><surname>Lewis</surname><given-names>MD</given-names></name><name><surname>Khan</surname><given-names>AA</given-names></name><name><surname>McCann</surname><given-names>CJ</given-names></name><name><surname>Francisco</surname><given-names>AF</given-names></name><name><surname>Jayawardhana</surname><given-names>S</given-names></name><etal/></person-group><article-title><italic>In Vivo</italic> Analysis of <italic>Trypanosoma cruzi</italic> Persistence Foci at Single-Cell Resolution</article-title><source>mBio</source><year>2020</year><volume>11</volume><issue>4</issue><elocation-id>e01242-20</elocation-id><pub-id pub-id-type="pmcid">PMC7407085</pub-id><pub-id pub-id-type="pmid">32753495</pub-id><pub-id pub-id-type="doi">10.1128/mBio.01242-20</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koman</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>BP</given-names></name><name><surname>Shilt</surname><given-names>JS</given-names></name></person-group><article-title>Cerebral palsy</article-title><source>The Lancet</source><year>2004</year><volume>363</volume><issue>9421</issue><fpage>1619</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">15145637</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheder</surname><given-names>A</given-names></name><name><surname>Nair</surname><given-names>KPS</given-names></name></person-group><article-title>Spasticity: pathophysiology, evaluation and management</article-title><source>Practical Neurology</source><year>2012</year><volume>12</volume><issue>5</issue><fpage>289</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">22976059</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyland</surname><given-names>KV</given-names></name><name><surname>Asfaw</surname><given-names>SH</given-names></name><name><surname>Olson</surname><given-names>CL</given-names></name><name><surname>Daniels</surname><given-names>MD</given-names></name><name><surname>Engman</surname><given-names>DM</given-names></name></person-group><article-title>Bioluminescent imaging of <italic>Trypanosoma cruzi</italic> infection</article-title><source>International journal for parasitology</source><year>2008</year><volume>38</volume><issue>12</issue><fpage>1391</fpage><lpage>400</lpage><pub-id pub-id-type="pmcid">PMC2583089</pub-id><pub-id pub-id-type="pmid">18511053</pub-id><pub-id pub-id-type="doi">10.1016/j.ijpara.2008.04.002</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzi</surname><given-names>HL</given-names></name><name><surname>Oliveira</surname><given-names>DN</given-names></name><name><surname>Lima</surname><given-names>MT</given-names></name><name><surname>Gattass</surname><given-names>CR</given-names></name></person-group><article-title><italic>Trypanosoma cruzi:</italic> Paninfectivity of CL Strain during Murine Acute Infection</article-title><source>Experimental parasitology</source><year>1996</year><volume>84</volume><issue>1</issue><fpage>16</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">8888730</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarner</surname><given-names>J</given-names></name><name><surname>Bartlett</surname><given-names>J</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name><name><surname>Colley</surname><given-names>DG</given-names></name><name><surname>Grijalva</surname><given-names>MJ</given-names></name><name><surname>Powell</surname><given-names>MR</given-names></name></person-group><article-title>Mouse model for Chagas disease: immunohistochemical distribution of different stages of <italic>Trypanosoma cruzi</italic> in tissues throughout infection</article-title><source>The American journal of tropical medicine and hygiene</source><year>2001</year><volume>65</volume><issue>2</issue><fpage>152</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11508392</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postan</surname><given-names>M</given-names></name><name><surname>Dvorak</surname><given-names>JA</given-names></name><name><surname>McDaniel</surname><given-names>JP</given-names></name></person-group><article-title>Studies of <italic>Trypanosoma cruzi</italic> Clones in Inbred Mice: I. A Comparison of the Course of Infection of C3H/HEN-Mice with Two Clones Isolated from a Common Source</article-title><source>The American journal of tropical medicine and hygiene</source><year>1983</year><volume>32</volume><issue>3</issue><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">6407346</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>R</given-names></name><name><surname>Brener</surname><given-names>Z</given-names></name></person-group><article-title>Tissue tropism of different <italic>Trypanosoma cruzi</italic> strains</article-title><source>J Parasitol</source><year>1978</year><volume>64</volume><issue>3</issue><fpage>475</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">96243</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postan</surname><given-names>M</given-names></name><name><surname>Bailey</surname><given-names>JJ</given-names></name><name><surname>Dvorak</surname><given-names>JA</given-names></name><name><surname>McDaniel</surname><given-names>JP</given-names></name><name><surname>Pottala</surname><given-names>EW</given-names></name></person-group><article-title>Studies of <italic>Trypanosoma cruzi</italic> Clones in Inbred Mice: III. Histopathological and Electrocardiographical Responses to Chronic Infection</article-title><source>The American journal of tropical medicine and hygiene</source><year>1987</year><volume>37</volume><issue>3</issue><fpage>541</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3318521</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>SG</given-names></name></person-group><article-title>Influence of Trypanosoma cruzi strain on the pathogenesis of chronic myocardiopathy in mice</article-title><source>Memorias do Instituto Oswaldo Cruz</source><year>1990</year><volume>85</volume><issue>1</issue><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">2215229</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francisco</surname><given-names>AF</given-names></name><name><surname>Jayawardhana</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>MC</given-names></name><name><surname>Lewis</surname><given-names>MD</given-names></name><name><surname>Kelly</surname><given-names>JM</given-names></name></person-group><article-title>Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease</article-title><source>Antimicrobial agents and chemotherapy</source><year>2018</year><volume>62</volume><issue>10</issue><pub-id pub-id-type="pmcid">PMC6153806</pub-id><pub-id pub-id-type="pmid">30082291</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00832-18</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadalawada</surname><given-names>S</given-names></name><name><surname>Sillau</surname><given-names>S</given-names></name><name><surname>Archuleta</surname><given-names>S</given-names></name><name><surname>Mundo</surname><given-names>W</given-names></name><name><surname>Bandali</surname><given-names>M</given-names></name><name><surname>Parra-Henao</surname><given-names>G</given-names></name><etal/></person-group><article-title>Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis</article-title><source>JAMA Network Open</source><year>2020</year><volume>3</volume><issue>8</issue><elocation-id>e2015072-e</elocation-id><pub-id pub-id-type="pmcid">PMC7489816</pub-id><pub-id pub-id-type="pmid">32865573</pub-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.15072</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>dos Santos</surname><given-names>VM</given-names></name><name><surname>de Lima</surname><given-names>MA</given-names></name><name><surname>Cabrine-Santos</surname><given-names>M</given-names></name><name><surname>de Stefani Marquez</surname><given-names>D</given-names></name><name><surname>de Araújo Pereira</surname><given-names>G</given-names></name><name><surname>Lages-Silva</surname><given-names>E</given-names></name><name><surname>Ramírez</surname><given-names>LE</given-names></name></person-group><article-title>Functional and histopathological study of the pancreas in hamsters (<italic>Mesocricetus auratus</italic>) infected and reinfected with <italic>Trypanosoma cruzi</italic></article-title><source>Parasitol Res</source><year>2004</year><volume>94</volume><issue>2</issue><fpage>125</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15322922</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AA</given-names></name><name><surname>Langston</surname><given-names>HC</given-names></name><name><surname>Walsh</surname><given-names>L</given-names></name><name><surname>Roscoe</surname><given-names>R</given-names></name><name><surname>Jayawardhana</surname><given-names>S</given-names></name><name><surname>Francisco</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy</article-title><comment>In Preparation</comment></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santi-Rocca</surname><given-names>J</given-names></name><name><surname>Fernandez-Cortes</surname><given-names>F</given-names></name><name><surname>Chillón-Marinas</surname><given-names>C</given-names></name><name><surname>González-Rubio</surname><given-names>M-L</given-names></name><name><surname>Martin</surname><given-names>D</given-names></name><name><surname>Gironès</surname><given-names>N</given-names></name><name><surname>Fresno</surname><given-names>M</given-names></name></person-group><article-title>A multi-parametric analysis of <italic>Trypanosoma cruzi</italic> infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses</article-title><source>Scientific Reports</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmcid">PMC5566495</pub-id><pub-id pub-id-type="pmid">28827716</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-08086-8</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>E</given-names></name><name><surname>Serna</surname><given-names>C</given-names></name><name><surname>Fragoso</surname><given-names>SP</given-names></name><name><surname>Nagarkatti</surname><given-names>R</given-names></name><name><surname>Debrabant</surname><given-names>A</given-names></name></person-group><article-title>A novel nanoluciferase-based system to monitor <italic>Trypanosoma cruzi</italic> infection in mice by bioluminescence imaging</article-title><source>PLOS ONE</source><year>2018</year><volume>13</volume><issue>4</issue><elocation-id>e0195879</elocation-id><pub-id pub-id-type="pmcid">PMC5908157</pub-id><pub-id pub-id-type="pmid">29672535</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0195879</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvet</surname><given-names>CM</given-names></name><name><surname>Silva</surname><given-names>TA</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>B</given-names></name><name><surname>Hirata</surname><given-names>K</given-names></name><name><surname>Siqueira-Neto</surname><given-names>JL</given-names></name><name><surname>McKerrow</surname><given-names>JH</given-names></name></person-group><article-title>Long term follow-up of <italic>Trypanosoma cruzi</italic> infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole</article-title><source>PLoS neglected tropical diseases</source><year>2020</year><volume>14</volume><issue>9</issue><elocation-id>e0008726</elocation-id><pub-id pub-id-type="pmcid">PMC7561097</pub-id><pub-id pub-id-type="pmid">32970692</pub-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0008726</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro Côbo</surname><given-names>E</given-names></name><name><surname>Silveira</surname><given-names>TP</given-names></name><name><surname>Micheletti</surname><given-names>AM</given-names></name><name><surname>Crema</surname><given-names>E</given-names></name><name><surname>Adad</surname><given-names>SJ</given-names></name></person-group><article-title>Research on <italic>Trypanosoma cruzi</italic> and Analysis of Inflammatory Infiltrate in Esophagus and Colon from Chronic Chagasic Patients with and without Mega</article-title><source>Journal of tropical medicine</source><year>2012</year><elocation-id>232646</elocation-id><pub-id pub-id-type="pmcid">PMC3206379</pub-id><pub-id pub-id-type="pmid">22131997</pub-id><pub-id pub-id-type="doi">10.1155/2012/232646</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adad</surname><given-names>SJ</given-names></name><name><surname>Andrade</surname><given-names>DCdS</given-names></name><name><surname>Lopes</surname><given-names>ER</given-names></name><name><surname>Chapadeiro</surname><given-names>E</given-names></name></person-group><article-title>Contribuição ao estudo da anatomia patológica do megaesôfago chagásico</article-title><source>Rev I Med Trop</source><year>1991</year><volume>33</volume><fpage>443</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">1844974</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silveira</surname><given-names>ABM</given-names></name><name><surname>Arantes</surname><given-names>RME</given-names></name><name><surname>Vago</surname><given-names>AR</given-names></name><name><surname>Lemos</surname><given-names>EM</given-names></name><name><surname>Adad</surname><given-names>SJ</given-names></name><name><surname>Correa-Oliveira</surname><given-names>R</given-names></name><name><surname>D’Avila Reis</surname><given-names>D</given-names></name></person-group><article-title>Comparative study of the presence of <italic>Trypanosoma cruzi</italic> kDNA, inflammation and denervation in chagasic patients with and without megaesophagus</article-title><source>Parasitology</source><year>2005</year><volume>131</volume><issue>05</issue><fpage>627</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">16255821</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>L</given-names></name><name><surname>Schijman</surname><given-names>AG</given-names></name><name><surname>Alonso-Padilla</surname><given-names>J</given-names></name><name><surname>Lozano</surname><given-names>D</given-names></name><name><surname>Torrico</surname><given-names>MC</given-names></name><name><surname>Gamba</surname><given-names>P</given-names></name><etal/></person-group><article-title>Molecular detection and parasite load of Trypanosoma cruzi in digestive tract tissue of Chagas disease patients affected by megacolon</article-title><source>Acta Trop</source><year>2022</year><volume>235</volume><elocation-id>106632</elocation-id><pub-id pub-id-type="pmid">35932843</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel-Gamboa</surname><given-names>L</given-names></name><name><surname>López-García</surname><given-names>L</given-names></name><name><surname>Moreno-Sánchez</surname><given-names>F</given-names></name><name><surname>Hoyo-Ulloa</surname><given-names>I</given-names></name><name><surname>Vega-Mémije</surname><given-names>ME</given-names></name><name><surname>Mendoza-Bazán</surname><given-names>N</given-names></name><etal/></person-group><article-title><italic>Trypanosoma cruzi</italic> infection associated with atypical clinical manifestation during the acute phase of the Chagas disease</article-title><source>Parasites &amp; Vectors</source><year>2019</year><volume>12</volume><issue>1</issue><fpage>506</fpage><pub-id pub-id-type="pmcid">PMC6822409</pub-id><pub-id pub-id-type="pmid">31666114</pub-id><pub-id pub-id-type="doi">10.1186/s13071-019-3766-3</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riganti</surname><given-names>J</given-names></name><name><surname>Maqueda</surname><given-names>MG</given-names></name><name><surname>Piñero</surname><given-names>MCB</given-names></name><name><surname>Volonteri</surname><given-names>VI</given-names></name><name><surname>Galimberti</surname><given-names>RL</given-names></name></person-group><article-title>Reactivation of Chagas’ disease: cutaneous manifestations in two immunosuppressed patients</article-title><source>International Journal of Dermatology</source><year>2012</year><volume>51</volume><issue>7</issue><fpage>829</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">22715827</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartori</surname><given-names>AM</given-names></name><name><surname>Sotto</surname><given-names>MN</given-names></name><name><surname>Braz</surname><given-names>LM</given-names></name><name><surname>Oliveira</surname><given-names>OdaC</given-names><suffix>Júnior</suffix></name><name><surname>Patzina</surname><given-names>RA</given-names></name><name><surname>Barone</surname><given-names>AA</given-names></name><name><surname>Shikanai-Yasuda</surname><given-names>MA</given-names></name></person-group><article-title>Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS</article-title><source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source><year>1999</year><volume>93</volume><issue>6</issue><fpage>631</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">10717752</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfituri</surname><given-names>OA</given-names></name><name><surname>Quintana</surname><given-names>JF</given-names></name><name><surname>MacLeod</surname><given-names>A</given-names></name><name><surname>Garside</surname><given-names>P</given-names></name><name><surname>Benson</surname><given-names>RA</given-names></name><name><surname>Brewer</surname><given-names>JM</given-names></name><etal/></person-group><article-title>To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host</article-title><source>Front Immunol</source><year>2020</year><volume>11</volume><fpage>1250</fpage><pub-id pub-id-type="pmcid">PMC7304505</pub-id><pub-id pub-id-type="pmid">32595652</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01250</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>OP</given-names></name><name><surname>Tiwary</surname><given-names>P</given-names></name><name><surname>Kushwaha</surname><given-names>AK</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Singh</surname><given-names>DK</given-names></name><name><surname>Lawyer</surname><given-names>P</given-names></name><etal/></person-group><article-title>Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study</article-title><source>Lancet Microbe</source><year>2021</year><volume>2</volume><issue>1</issue><fpage>e23</fpage><lpage>e31</lpage><pub-id pub-id-type="pmcid">PMC7869864</pub-id><pub-id pub-id-type="pmid">33615281</pub-id><pub-id pub-id-type="doi">10.1016/S2666-5247(20)30166-X</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morillo</surname><given-names>CA</given-names></name><name><surname>Marin-Neto</surname><given-names>JA</given-names></name><name><surname>Avezum</surname><given-names>A</given-names></name><name><surname>Sosa-Estani</surname><given-names>S</given-names></name><name><surname>Rassi</surname><given-names>AJ</given-names></name><name><surname>Rosas</surname><given-names>F</given-names></name><etal/></person-group><article-title>Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy</article-title><source>New England Journal of Medicine</source><year>2015</year><volume>373</volume><issue>14</issue><fpage>1295</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">26323937</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>GL</given-names></name><name><surname>Giannini</surname><given-names>SH</given-names></name></person-group><article-title>Sarcocystis, Trypanosoma, Toxoplasma, Brugia, Ancylostoma, and Trichinella spp.: A review of the intracellular parasites of striated muscle</article-title><source>Experimental parasitology</source><year>1982</year><volume>53</volume><issue>3</issue><fpage>406</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">6806117</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>JD</given-names></name><name><surname>Hoffman</surname><given-names>VJ</given-names></name><name><surname>Roffe</surname><given-names>E</given-names></name><name><surname>Murphy</surname><given-names>PM</given-names></name></person-group><article-title>Low-level parasite Persistence drives vasculitis and myositis in skeletal muscle of mice chronically infected with <italic>Trypanosoma cruzi</italic></article-title><source>Infection and immunity</source><year>2019</year><volume>87</volume><issue>6</issue><elocation-id>e00081-19</elocation-id><pub-id pub-id-type="pmcid">PMC6529661</pub-id><pub-id pub-id-type="pmid">30936158</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00081-19</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roffê</surname><given-names>E</given-names></name><name><surname>Marino</surname><given-names>APMP</given-names></name><name><surname>Weaver</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>W</given-names></name><name><surname>de Araújo</surname><given-names>FF</given-names></name><name><surname>Hoffman</surname><given-names>V</given-names></name><etal/></person-group><article-title><italic>Trypanosoma cruzi</italic> Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice</article-title><source>Infection and immunity</source><year>2016</year><volume>84</volume><issue>4</issue><fpage>1123</fpage><lpage>36</lpage><pub-id pub-id-type="pmcid">PMC4807493</pub-id><pub-id pub-id-type="pmid">26857570</pub-id><pub-id pub-id-type="doi">10.1128/IAI.01497-15</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bombeiro</surname><given-names>AL</given-names></name><name><surname>Gonçalves</surname><given-names>LA</given-names></name><name><surname>Penha-Gonçalves</surname><given-names>C</given-names></name><name><surname>Marinho</surname><given-names>CRF</given-names></name><name><surname>D’Imperio Lima</surname><given-names>MR</given-names></name><name><surname>Chadi</surname><given-names>G</given-names></name><name><surname>Álvarez</surname><given-names>JM</given-names></name></person-group><article-title>IL-12p40 Deficiency Leads to Uncontrolled <italic>Trypanosoma cruzi</italic> Dissemination in the Spinal Cord Resulting in Neuronal Death and Motor Dysfunction</article-title><source>PLOS ONE</source><year>2012</year><volume>7</volume><issue>11</issue><elocation-id>e49022</elocation-id><pub-id pub-id-type="pmcid">PMC3495776</pub-id><pub-id pub-id-type="pmid">23152844</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0049022</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genovese</surname><given-names>O</given-names></name><name><surname>Ballario</surname><given-names>C</given-names></name><name><surname>Storino</surname><given-names>R</given-names></name><name><surname>Segura</surname><given-names>E</given-names></name><name><surname>Sica</surname><given-names>RE</given-names></name></person-group><article-title>Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease</article-title><source>Arq Neuropsiquiatr</source><year>1996</year><volume>54</volume><issue>2</issue><fpage>190</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8984973</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sica</surname><given-names>RE</given-names></name><name><surname>Genovese</surname><given-names>OM</given-names></name><name><surname>Gargia Erro</surname><given-names>M</given-names></name></person-group><article-title>Peripheral motor nerve conduction studies in patients with chronic Chagas’ disease</article-title><source>Arq Neuropsiquiatr</source><year>1991</year><volume>49</volume><issue>4</issue><fpage>405</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1668781</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laguens</surname><given-names>R</given-names></name><name><surname>Cossio</surname><given-names>P</given-names></name><name><surname>Diez</surname><given-names>C</given-names></name><name><surname>Segal</surname><given-names>A</given-names></name><name><surname>Vasquez</surname><given-names>C</given-names></name><name><surname>Kreutzer</surname><given-names>E</given-names></name><etal/></person-group><article-title>Immunopathologic and morphologic studies of skeletal muscle in Chagas’ disease</article-title><source>The American journal of pathology</source><year>1975</year><volume>80</volume><issue>1</issue><fpage>153</fpage><pub-id pub-id-type="pmcid">PMC1912837</pub-id><pub-id pub-id-type="pmid">125546</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>SH</given-names></name><name><surname>Finol</surname><given-names>HJ</given-names></name><name><surname>Montes de Oca</surname><given-names>M</given-names></name><name><surname>Vásquez</surname><given-names>F</given-names></name><name><surname>Puigbó</surname><given-names>JJ</given-names></name><name><surname>Loyo</surname><given-names>JG</given-names></name></person-group><article-title>Capillary damage in skeletal muscle in advanced Chagas’ disease patients</article-title><source>Parasitol Res</source><year>2004</year><volume>93</volume><issue>5</issue><fpage>364</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15205941</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montes de Oca</surname><given-names>M</given-names></name><name><surname>Torres</surname><given-names>SH</given-names></name><name><surname>Loyo</surname><given-names>JG</given-names></name><name><surname>Vazquez</surname><given-names>F</given-names></name><name><surname>Hernández</surname><given-names>N</given-names></name><name><surname>Anchustegui</surname><given-names>B</given-names></name><name><surname>Puigbó</surname><given-names>JJ</given-names></name></person-group><article-title>Exercise performance and skeletal muscles in patients with advanced Chagas disease</article-title><source>Chest</source><year>2004</year><volume>125</volume><issue>4</issue><fpage>1306</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15078739</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taratuto</surname><given-names>A</given-names></name><name><surname>Pagano</surname><given-names>MA</given-names></name><name><surname>Fumo</surname><given-names>T</given-names></name><name><surname>Sanz</surname><given-names>OP</given-names></name><name><surname>Sica</surname><given-names>RE</given-names></name></person-group><article-title>Histological and histochemical changes of the skeletal muscle in human chronic Chagas’ disease</article-title><source>Arq Neuropsiquiatr</source><year>1978</year><volume>36</volume><issue>4</issue><fpage>327</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">87186</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benavente</surname><given-names>OR</given-names></name><name><surname>Patiño</surname><given-names>OL</given-names></name><name><surname>Peña</surname><given-names>LB</given-names></name><name><surname>Lugònes</surname><given-names>H</given-names></name><name><surname>Kalala</surname><given-names>E</given-names></name><name><surname>Meneclier</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Motor unit involvement in human acute Chagas’ disease</article-title><source>Arq Neuropsiquiatr</source><year>1989</year><volume>47</volume><issue>3</issue><fpage>283</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2559681</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Serial evaluation of <italic>T. cruzi</italic> CLBR infection in Syrian hamsters by <italic>in vivo</italic> bioluminescence imaging.</title><p><bold>A, B:</bold> Course of transgenic bioluminescent TcVI-CLBR infection in female Syrian hamsters tracked by <italic>in vivo</italic> imaging. <bold>A:</bold> Panels show an example series of ventral images for one hamster per group taken at the indicated times post-infection. Log-scale pseudocolour heat-map shows intensity of bioluminescence as a proxy for parasite load; minimum and maximum radiances are indicated. <bold>B</bold>: Chart shows the changes in mean ±S.E.M., total bioluminescence over time for hamsters inoculated with 5 x 10<sup>3</sup> (low inoculum, n = 3) or 1 x 10<sup>5</sup> (high inoculum, n = 8) parasites. Threshold lines are the mean (dashes) and the mean +2SD (dots) of background signal obtained for uninfected control hamsters (n = 7). <bold>C</bold>: Evaluation of organ sizes/weights and the number of faecal pellets present in the colon at 152-182 post-infection (high inoculum group (n = 8-9 with the exception of GI mesentery, n = 5, and faecal pellets n = 6), uninfected control group (n = 8, with the exception of GI mesentery and faecal pellets, n = 4). Asterisks indicate <italic>p</italic>-values for comparisons with the uninfected control group in multiple unpaired <italic>t</italic>-tests (*** <italic>p</italic>&lt;0.001, * <italic>p</italic>&lt;0.05).</p></caption><graphic xlink:href="EMS190915-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Organ-specific infection profiles of <italic>T. cruzi</italic> CLBR in Syrian hamsters.</title><p>Quantification of organ/tissue-specific parasite loads and densities in TcVI-CLBR-infected Syrian hamsters using <italic>ex vivo</italic> bioluminescence imaging at 34-38 days (n = 6) and 152-182 days (n = 9) post-infection. Images (<bold>A</bold>) show bioluminescence intensities for one representative animal per group. Layout of samples shown on the uninfected control image: 1 = liver (partial), 2 = lungs, 3 = heart (bisected), 4 = kidneys, 5 = spleen, 6 = visceral adipose, 7 = female reproductive system, 8 = bladder, 9 = skeletal muscle (from hindleg), 10 = oesophagus, 11 = stomach, 12 = small intestine, 13 = gastro-intestinal mesentery, 14 = peritoneum/abdominal muscle, 15 = caecum, 16 = colon, 17 = subcutaneous adipose, 18 = visceral adipose, 19 = skin. <bold>B,C</bold>: Quantification of total bioluminescent flux (photons/sec) as a proxy of parasite loads for each organ and tissue type at 34-38 days (<bold>B</bold>) and 152-182 days (<bold>C</bold>) post-infection. <bold>D,E</bold>: Charts show the average proportional distributions of total measured <italic>ex vivo</italic> parasite loads (total flux, p/s) across the analysed set of organ and tissue types at 34-38 days (<bold>D</bold>) and 152-182 days (<bold>E</bold>) post-infection <bold>F,G</bold>: Quantification of bioluminescent radiance (photons/sec/cm<sup>2</sup>/sr) as a proxy of infection intensity for each organ and tissue type expressed as fold change vs. matching organs or tissues from uninfected controls at 34-38 days (<bold>F</bold>) and 152-182 days (<bold>G</bold>) post-infection. Dashed line indicates detection threshold. In <bold>B</bold>, <bold>C</bold>, <bold>F</bold> and <bold>G</bold>, bars show the mean + S.E.M., and grey circles are data for individual hamsters.</p></caption><graphic xlink:href="EMS190915-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Histopathological analysis of cardiac muscle tissue from <italic>T. cruzi</italic>-infected Syrian hamsters.</title><p>Quantification of cellularity (<bold>A</bold>) and collagen content (<bold>B</bold>) as markers of myocardial inflammation and fibrosis, respectively. Bars show the means + S.E.M., and grey circles are data for individual hamsters. Uninfected control (n = 7), infected (n = 9). Images show representative example sections with haematoxylin and eosin (<bold>A</bold>), and picro-sirius red (<bold>B</bold>). Magnification 400X, scale bar = 50 μm.</p></caption><graphic xlink:href="EMS190915-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Evaluation of limb adduction in <italic>T. cruzi</italic>-infected Syrian hamsters.</title><p><bold>A:</bold> Example ventral view images of an individual hamster under transient anaesthesia (gaseous isoflurane) at the indicated day post-infection, with an age-matched uninfected control. Red marker lines highlight the inter-hindpaw distances. <bold>B – E</bold>: Quantification of the distance between forepaws (<bold>B</bold>, <bold>C</bold>) and hindpaws (<bold>D</bold>, <bold>E</bold>). In <bold>B</bold> and <bold>D</bold>, data are shown as the mean ± S.E.M. over time, uninfected control (n=2), infected (n=4). In <bold>C</bold> and <bold>E</bold>, data are the mean + S.E.M at the endpoint, with grey circles showing the measurements for individual animals, uninfected control (n=5), infected (n=7) (<bold>C</bold>, <bold>E</bold>).</p></caption><graphic xlink:href="EMS190915-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Histopathological analysis of quadriceps tissue from <italic>T. cruzi</italic>-infected Syrian hamsters.</title><p>Quantification of cellularity (<bold>A</bold>) and collagen content (<bold>B</bold>) as markers of skeletal muscle inflammation and fibrosis, respectively. Bars show the means + S.E.M., and grey circles are data for individual hamsters. Uninfected control (n = 7), infected (n = 9). Images show representative example sections with haematoxylin and eosin (<bold>A</bold>), and picro-sirius red (<bold>B</bold>). Magnification 400X, scale bar = 50 μm. <italic>P</italic>-values shown are from Student’s <italic>t</italic>-tests.</p></caption><graphic xlink:href="EMS190915-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Histopathological analysis of skeletal muscle tissue from multiple murine <italic>T. cruzi</italic> models.</title><p><bold>A:</bold> Representative myocardial sections stained with haematoxylin and eosin, magnification 400X, scale bar = 100 μm. <bold>B:</bold> Quantitative histopathological analysis of myocardium samples obtained at 154-174 days post-infection from the following groups: TcVI-CLBR-BALB/c (n = 9), TcVI-CLBR-C57BL/6 (n = 10), TcVI-CLBR-C3H/HeN (n = 10), TcI-JR-BALB/c (n = 10), TcI-JR-C57BL/6 (n = 10), TcI-JR-C3H/HeN (n = 8), uninfected control BALB/c, C57BL.6 and C3H/HeN (all n = 10). Myositis score is the number of nuclei per image (6 x 10<sup>4</sup> μm<sup>2</sup>). In <bold>A</bold> and <bold>B</bold>, black and white arrows indicate examples of parasite nests and areas of adipose replacement respectively. <bold>C:</bold> Representative myocardial sections stained with Masson’s trichrome, magnification 400X, scale bar = 100 μm. <bold>D:</bold> Quantification of collagen content (% blue area) as a marker of cardiac fibrosis severity in same groups as in <bold>B</bold>. Data are the means +S.E.M. and are from two independent experiments. Asterisks indicate <italic>p</italic>-values for one way ANOVA comparisons between infection status groups, with each mouse strain analysed independently (* <italic>P</italic> &lt; 0.05; ** <italic>P</italic> &lt; 0.01; *** <italic>P</italic> &lt; 0.001).</p></caption><graphic xlink:href="EMS190915-f006"/></fig></floats-group></article>